No Data
No Data
Here's Why Elevance Health (ELV) Declined in Q4
Insiders At Elevance Health Sold US$12m In Stock, Alluding To Potential Weakness
Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $585
What Gives Elevance Health (ELV) an Attractive Opportunity in The Large Cap Space?
New Analyst Forecast: $ELV Given 'Outperform' Rating
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)